165 related articles for article (PubMed ID: 25633211)
1. Gene therapy in peripheral artery disease.
Sanada F; Taniyama Y; Kanbara Y; Otsu R; Ikeda-Iwabu Y; Carracedo M; Rakugi H; Morishita R
Expert Opin Biol Ther; 2015 Mar; 15(3):381-90. PubMed ID: 25633211
[TBL] [Abstract][Full Text] [Related]
2. Gene therapy for peripheral arterial disease.
Shimamura M; Nakagami H; Taniyama Y; Morishita R
Expert Opin Biol Ther; 2014 Aug; 14(8):1175-84. PubMed ID: 24766232
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic Angiogenesis by Gene Therapy for Critical Limb Ischemia: Choice of Biological Agent.
Sanada F; Taniyama Y; Azuma J; Yuka II; Kanbara Y; Iwabayashi M; Rakugi H; Morishita R
Immunol Endocr Metab Agents Med Chem; 2014 Apr; 14(1):32-39. PubMed ID: 26005508
[TBL] [Abstract][Full Text] [Related]
4. Clinical Safety and Preliminary Efficacy of Plasmid pUDK-HGF Expressing Human Hepatocyte Growth Factor (HGF) in Patients with Critical Limb Ischemia.
Cui S; Guo L; Li X; Gu Y; Fu J; Dong L; Song H; Chen X; Lu Y; Hu C; Xiao F; Zhu D; Wu Z; Zhang Q
Eur J Vasc Endovasc Surg; 2015 Oct; 50(4):494-501. PubMed ID: 26122834
[TBL] [Abstract][Full Text] [Related]
5. Combined Analysis of Clinical Data on HGF Gene Therapy to Treat Critical Limb Ischemia in Japan.
Morishita R; Shimamura M; Takeya Y; Nakagami H; Chujo M; Ishihama T; Yamada E; Rakugi H
Curr Gene Ther; 2020; 20(1):25-35. PubMed ID: 32416690
[TBL] [Abstract][Full Text] [Related]
6. Gene-based therapies in patients with critical limb ischemia.
Kitrou P; Karnabatidis D; Brountzos E; Katsanos K; Reppas L; Spiliopoulos S
Expert Opin Biol Ther; 2017 Apr; 17(4):449-456. PubMed ID: 28133976
[TBL] [Abstract][Full Text] [Related]
7. Treatment of Critical Limb Ischemia by pIRES/VEGF165/HGF Administration.
Barć P; Antkiewicz M; Śliwa B; Baczyńska D; Witkiewicz W; Skóra JP
Ann Vasc Surg; 2019 Oct; 60():346-354. PubMed ID: 31200059
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic angiogenesis: recent and future prospects of gene therapy in peripheral artery disease.
Tanaka M; Taketomi K; Yonemitsu Y
Curr Gene Ther; 2014; 14(4):300-8. PubMed ID: 25197884
[TBL] [Abstract][Full Text] [Related]
9. Gene therapy for therapeutic angiogenesis in peripheral arterial disease - a systematic review and meta-analysis of randomized, controlled trials.
Hammer A; Steiner S
Vasa; 2013 Sep; 42(5):331-9. PubMed ID: 23989068
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic angiogenesis for revascularization in peripheral artery disease.
Grochot-Przeczek A; Dulak J; Jozkowicz A
Gene; 2013 Aug; 525(2):220-8. PubMed ID: 23566831
[TBL] [Abstract][Full Text] [Related]
11. Double VEGF/HGF Gene Therapy in Critical Limb Ischemia Complicated by Diabetes Mellitus.
Barć P; Antkiewicz M; Śliwa B; Frączkowska K; Guziński M; Dawiskiba T; Małodobra-Mazur M; Witkiewicz W; Kupczyńska D; Strzelec B; Janczak D; Skóra JP
J Cardiovasc Transl Res; 2021 Jun; 14(3):409-415. PubMed ID: 32875492
[TBL] [Abstract][Full Text] [Related]
12. Angiogenesis in peripheral arterial disease.
Inampudi C; Akintoye E; Ando T; Briasoulis A
Curr Opin Pharmacol; 2018 Apr; 39():60-67. PubMed ID: 29529399
[TBL] [Abstract][Full Text] [Related]
13. Gene therapy and cell-based therapies for therapeutic angiogenesis in peripheral artery disease.
Shimamura M; Nakagami H; Koriyama H; Morishita R
Biomed Res Int; 2013; 2013():186215. PubMed ID: 24294599
[TBL] [Abstract][Full Text] [Related]
14. Safety evaluation of clinical gene therapy using hepatocyte growth factor to treat peripheral arterial disease.
Morishita R; Aoki M; Hashiya N; Makino H; Yamasaki K; Azuma J; Sawa Y; Matsuda H; Kaneda Y; Ogihara T
Hypertension; 2004 Aug; 44(2):203-9. PubMed ID: 15238569
[TBL] [Abstract][Full Text] [Related]
15. A Randomized, Double-Blind, Placebo-Controlled Phase II Study of Hepatocyte Growth Factor in the Treatment of Critical Limb Ischemia.
Gu Y; Cui S; Wang Q; Liu C; Jin B; Guo W; Liu C; Chu T; Shu C; Zhang F; Han C; Liu Y
Mol Ther; 2019 Dec; 27(12):2158-2165. PubMed ID: 31805256
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic Benefits and Adverse Effects of Combined Proangiogenic Gene Therapy in Mouse Critical Leg Ischemia.
Lebas B; Galley J; Renaud-Gabardos E; Pujol F; Lenfant F; Garmy-Susini B; Chaufour X; Prats AC
Ann Vasc Surg; 2017 Apr; 40():252-261. PubMed ID: 27903483
[TBL] [Abstract][Full Text] [Related]
17. Trimodal rescue of hind limb ischemia with growth factors, cells, and nanocarriers: fundamentals to clinical trials.
Lakshmanan R; Ukani G; Rishi MT; Maulik N
Can J Physiol Pharmacol; 2017 Oct; 95(10):1125-1140. PubMed ID: 28407473
[TBL] [Abstract][Full Text] [Related]
18. Insights into gene therapy for critical limb ischemia: the devil is in the details.
Madonna R; Rokosh G
Vascul Pharmacol; 2012 Aug; 57(1):10-4. PubMed ID: 22580542
[TBL] [Abstract][Full Text] [Related]
19. Safety and efficacy of patient specific intramuscular injection of HGF plasmid gene therapy on limb perfusion and wound healing in patients with ischemic lower extremity ulceration: results of the HGF-0205 trial.
Powell RJ; Goodney P; Mendelsohn FO; Moen EK; Annex BH;
J Vasc Surg; 2010 Dec; 52(6):1525-30. PubMed ID: 21146749
[TBL] [Abstract][Full Text] [Related]
20. Endothelial progenitor cells in clinical settings.
Sanada S; Taniyama Y; Azuma J; Yuka II; Iwabayashi M; Rakugi H; Morishita R
J Stem Cells; 2014; 9(2):117-25. PubMed ID: 25158160
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
